By Taylor Kubota
Five years ago, the Chan Zuckerberg Initiative (CZI) launched the Chan Zuckerberg Biohub, a Bay Area research collaboration between Stanford University, the University of California, Berkeley, and the University of California, San Francisco (UCSF). The Biohub aims to better understand the fundamentals of disease and develop new technologies that could lead to more actionable diagnostics and effective therapies.
In a Dec. 7 announcement about new and renewed support for science and science technology, CZI revealed an extension of the Biohub’s operations through 2031. The announcement commended the collaboration’s work over the past five years on COVID-19 response, emerging diseases, whole-organism cell atlases and protein interactions within cells, among other projects.
Citing the success of the Biohub, CZI also announced the formation of a CZ Biohub Network. This will support the development of new Biohub collaborations in other locations to “take on grand scientific challenges in areas such as imaging, artificial intelligence, infectious disease research, cell biology and neuroscience while building new technologies and tools to tackle them,” according to the CZI press release.